Track the 株式会社コスモス薬品 share price and the full management transaction log of the company, a listed equity based in Japan. Shares are listed on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Retail sector, 株式会社コスモス薬品 has logged 8 insider filings. Market capitalisation: €494.2bn. The latest transaction was disclosed on 5 March 2025 (Holding update). Among the most active insiders: JPMorgan Asset Management (Japan) Limited. All data is accessible without an account.
Analysts rate 株式会社コスモス薬品 Buy (bullish), based on 10 analysts. Average price target: JP¥7,571.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
Cosmos Pharmaceutical Corporation 是一家日本公司,专门从事药品和消费品的销售。它主要在日本的药店和零售市场运营。